Evidence map›Paper›PMID 25368195›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Impact of early-stage HIV transmission on treatment as prevention.

Kimberly A Powers, Mirjam E Kretzschmar, William C Miller, Myron S Cohen

Abstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Speed and strength of an epidemic intervention.Proceedings. Biological sciences · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The missing 27.AIDS (London, England) · 2017
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Kimberly A PowersDepartment of Epidemiology, powersk@email.unc.edu.
Mirjam E KretzschmarCentre for Infectious Disease Control, National Institute of Public Health and the Environment, 3721MA, Bilthoven, The Netherlands; and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584CX, Utrecht, The Netherlands.
William C MillerDepartment of Epidemiology, Division of Infectious Diseases, and.
Myron S CohenDepartment of Epidemiology, Division of Infectious Diseases, and Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
NIAID NIH HHS P30 AI050410
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EpidemicsHIV-1Models, BiologicalAnti-Retroviral AgentsFemaleHIV InfectionsHumansMaleAnti-Retroviral Agents

Identifiers

PMID25368195
PMCPMC4234559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.